HEADER CHAPERONE 09-SEP-03 1QY5 OBSLTE 16-MAY-18 1QY5 6D28 TITLE CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 IN TITLE 2 COMPLEX WITH THE SPECIFIC LIGAND NECA COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOPLASMIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 69-337; COMPND 5 SYNONYM: 94 KDA GLUCOSE-REGULATED PROTEIN, GRP94; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 STRAIN: FAMILIARIS; SOURCE 6 GENE: TRA1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PGEXNB KEYWDS GRP94, NECA, HSP90, CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR K.L.SOLDANO,A.JIVAN,C.V.NICCHITTA,D.T.GEWIRTH REVDAT 4 16-MAY-18 1QY5 1 OBSLTE REMARK REVDAT 3 24-FEB-09 1QY5 1 VERSN REVDAT 2 23-DEC-03 1QY5 1 JRNL REVDAT 1 11-NOV-03 1QY5 0 JRNL AUTH K.L.SOLDANO,A.JIVAN,C.V.NICCHITTA,D.T.GEWIRTH JRNL TITL STRUCTURE OF THE N-TERMINAL DOMAIN OF GRP94. BASIS FOR JRNL TITL 2 LIGAND SPECIFICITY AND REGULATION JRNL REF J.BIOL.CHEM. V. 278 48330 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12970348 JRNL DOI 10.1074/JBC.M308661200 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1245770.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 27616 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2747 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2293 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE : 0.3070 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 230 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1722 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 227 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.68000 REMARK 3 B22 (A**2) : 3.51000 REMARK 3 B33 (A**2) : -5.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.11 REMARK 3 LOW RESOLUTION CUTOFF (A) : 50.1 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.022 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.130 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.480 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.310 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.280 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.300 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 78.90 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NECA.PARAM REMARK 3 PARAMETER FILE 3 : 3PG.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NECA.TOP REMARK 3 TOPOLOGY FILE 4 : 3PG.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1QY5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1000020211. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-SEP-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28627 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 8.200 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 47.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1AMW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 400, MAGNESIUM CHLORIDE, TRIS, PH REMARK 280 7.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.53550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.53550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.60000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.59000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.60000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.59000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 31.53550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.60000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 49.59000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 31.53550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.60000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 49.59000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 69 REMARK 465 ARG A 70 REMARK 465 GLU A 71 REMARK 465 GLU A 287 REMARK 465 THR A 288 REMARK 465 VAL A 289 REMARK 465 GLU A 290 REMARK 465 GLU A 291 REMARK 465 PRO A 292 REMARK 465 MET A 293 REMARK 465 GLU A 294 REMARK 465 GLU A 295 REMARK 465 GLU A 296 REMARK 465 GLU A 297 REMARK 465 ALA A 298 REMARK 465 ALA A 299 REMARK 465 LYS A 300 REMARK 465 GLU A 301 REMARK 465 GLU A 302 REMARK 465 LYS A 303 REMARK 465 GLU A 304 REMARK 465 ASP A 305 REMARK 465 SER A 306 REMARK 465 ASP A 307 REMARK 465 ASP A 308 REMARK 465 GLU A 309 REMARK 465 ALA A 310 REMARK 465 ALA A 311 REMARK 465 VAL A 312 REMARK 465 GLU A 313 REMARK 465 GLU A 314 REMARK 465 GLU A 315 REMARK 465 GLU A 316 REMARK 465 GLU A 317 REMARK 465 GLU A 318 REMARK 465 LYS A 319 REMARK 465 LYS A 320 REMARK 465 PRO A 321 REMARK 465 LYS A 322 REMARK 465 THR A 323 REMARK 465 LYS A 324 REMARK 465 LYS A 325 REMARK 465 VAL A 326 REMARK 465 GLU A 327 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 75 CG CD CE NZ REMARK 470 LYS A 114 CG CD CE NZ REMARK 470 GLU A 123 CG CD OE1 OE2 REMARK 470 GLU A 131 CG CD OE1 OE2 REMARK 470 LYS A 140 CG CD CE NZ REMARK 470 LYS A 142 CG CD CE NZ REMARK 470 ASN A 143 CG OD1 ND2 REMARK 470 GLU A 157 CG CD OE1 OE2 REMARK 470 LYS A 161 CG CD CE NZ REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 GLU A 229 CG CD OE1 OE2 REMARK 470 GLN A 273 CG CD OE1 NE2 REMARK 470 PHE A 274 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN A 276 CG OD1 ND2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 116 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 463 O HOH A 504 1.98 REMARK 500 O HOH A 462 O HOH A 512 1.98 REMARK 500 O ALA A 111 O HOH A 570 2.08 REMARK 500 O HOH A 468 O HOH A 523 2.14 REMARK 500 OE1 GLU A 74 NH2 ARG A 156 2.18 REMARK 500 OD1 ASN A 91 O HOH A 598 2.19 REMARK 500 N ILE A 115 O HOH A 570 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 C6 M2M A 401 C6 M2M A 401 4557 1.90 REMARK 500 O HOH A 600 O HOH A 600 3556 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 96 57.12 -142.94 REMARK 500 ASN A 129 115.67 -170.03 REMARK 500 SER A 227 -10.61 87.77 REMARK 500 GLU A 229 174.49 172.70 REMARK 500 TYR A 271 -16.20 77.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NEC A 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE M2M A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QY8 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH RADICICOL DBREF 1QY5 A 69 337 UNP P41148 ENPL_CANFA 69 337 SEQRES 1 A 269 LEU ARG GLU LYS SER GLU LYS PHE ALA PHE GLN ALA GLU SEQRES 2 A 269 VAL ASN ARG MET MET LYS LEU ILE ILE ASN SER LEU TYR SEQRES 3 A 269 LYS ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SEQRES 4 A 269 ALA SER ASP ALA LEU ASP LYS ILE ARG LEU ILE SER LEU SEQRES 5 A 269 THR ASP GLU ASN ALA LEU ALA GLY ASN GLU GLU LEU THR SEQRES 6 A 269 VAL LYS ILE LYS CYS ASP LYS GLU LYS ASN LEU LEU HIS SEQRES 7 A 269 VAL THR ASP THR GLY VAL GLY MET THR ARG GLU GLU LEU SEQRES 8 A 269 VAL LYS ASN LEU GLY THR ILE ALA LYS SER GLY THR SER SEQRES 9 A 269 GLU PHE LEU ASN LYS MET THR GLU ALA GLN GLU ASP GLY SEQRES 10 A 269 GLN SER THR SER GLU LEU ILE GLY GLN PHE GLY VAL GLY SEQRES 11 A 269 PHE TYR SER ALA PHE LEU VAL ALA ASP LYS VAL ILE VAL SEQRES 12 A 269 THR SER LYS HIS ASN ASN ASP THR GLN HIS ILE TRP GLU SEQRES 13 A 269 SER ASP SER ASN GLU PHE SER VAL ILE ALA ASP PRO ARG SEQRES 14 A 269 GLY ASN THR LEU GLY ARG GLY THR THR ILE THR LEU VAL SEQRES 15 A 269 LEU LYS GLU GLU ALA SER ASP TYR LEU GLU LEU ASP THR SEQRES 16 A 269 ILE LYS ASN LEU VAL LYS LYS TYR SER GLN PHE ILE ASN SEQRES 17 A 269 PHE PRO ILE TYR VAL TRP SER SER LYS THR GLU THR VAL SEQRES 18 A 269 GLU GLU PRO MET GLU GLU GLU GLU ALA ALA LYS GLU GLU SEQRES 19 A 269 LYS GLU ASP SER ASP ASP GLU ALA ALA VAL GLU GLU GLU SEQRES 20 A 269 GLU GLU GLU LYS LYS PRO LYS THR LYS LYS VAL GLU LYS SEQRES 21 A 269 THR VAL TRP ASP TRP GLU LEU MET ASN HET NEC A 338 22 HET M2M A 401 9 HETNAM NEC N-ETHYL-5'-CARBOXAMIDO ADENOSINE HETNAM M2M 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE FORMUL 2 NEC C12 H16 N6 O4 FORMUL 3 M2M C6 H14 O3 FORMUL 4 HOH *227(H2 O) HELIX 1 1 GLN A 79 TYR A 94 1 16 HELIX 2 2 GLU A 98 ASP A 122 1 25 HELIX 3 3 THR A 155 THR A 165 1 11 HELIX 4 4 LYS A 168 GLY A 185 1 18 HELIX 5 5 THR A 188 PHE A 195 1 8 HELIX 6 6 VAL A 197 LEU A 204 5 8 HELIX 7 7 GLU A 253 LEU A 259 5 7 HELIX 8 8 GLU A 260 LYS A 270 1 11 SHEET 1 A 9 SER A 73 PHE A 76 0 SHEET 2 A 9 PHE A 230 ALA A 234 -1 O PHE A 230 N PHE A 76 SHEET 3 A 9 HIS A 221 SER A 225 -1 N ILE A 222 O ILE A 233 SHEET 4 A 9 ALA A 206 LYS A 214 -1 N VAL A 211 O TRP A 223 SHEET 5 A 9 GLY A 244 LEU A 251 -1 O THR A 248 N ILE A 210 SHEET 6 A 9 LEU A 144 ASP A 149 -1 N LEU A 145 O LEU A 249 SHEET 7 A 9 VAL A 134 ASP A 139 -1 N LYS A 135 O THR A 148 SHEET 8 A 9 ILE A 279 SER A 284 1 O TYR A 280 N VAL A 134 SHEET 9 A 9 TRP A 331 ASN A 337 -1 O GLU A 334 N VAL A 281 SITE 1 AC1 15 ASN A 107 ALA A 111 ASP A 149 MET A 154 SITE 2 AC1 15 ASN A 162 LEU A 163 VAL A 197 PHE A 199 SITE 3 AC1 15 TYR A 200 THR A 245 HOH A 402 HOH A 403 SITE 4 AC1 15 HOH A 421 HOH A 427 HOH A 521 SITE 1 AC2 6 ASN A 83 MET A 86 LYS A 87 SER A 227 SITE 2 AC2 6 HOH A 416 HOH A 435 CRYST1 89.200 99.180 63.071 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011211 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010083 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015855 0.00000